Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.85
+0.35 (1.27%)
Mar 10, 2026, 9:00 AM CST

Prince Pharmaceutical Company Description

Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.

The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine.

Prince Pharmaceutical Co., Ltd. was founded in 1962 and is headquartered in Yunlin County, Taiwan.

Prince Pharmaceutical Co., Ltd.
Country Taiwan
Founded 1962
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 210
CEO Da Li

Contact Details

Address:
No.168, Keyun S. Road
Yunlin County, 632
Taiwan
Phone 886 5 632 6910
Website prince-pharm.com.tw

Stock Details

Ticker Symbol 6935
Exchange Taipei Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency TWD
ISIN Number TW0006935000
SIC Code 2834

Key Executives

Name Position
Da Li GM and Chairman
Cuiwei Chen Accounting Supervisor